Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 25 of 118

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
24/7 EEG SubQ for epilepsyMIB277
3C Patch for treating diabetic foot ulcersHTG615
Acute heart failure: diagnosis and managementCG187
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adultsES40
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infectionsES39
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Brain tumours (primary) and brain metastases in over 16sQS203
Cabotegravir with rilpivirine for treating HIV-1TA757
CerebAir for continuous EEG monitoring in intensive careMIB279
Chronic kidney disease: assessment and managementNG203
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsHTG602
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemiaMIB278
Colorectal cancerNG151
Colorectal cancerQS20
Coronary sinus narrowing device implantation for refractory anginaHTG600
d-Nav insulin management app for type 2 diabetesMIB285
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
Diabetes in children and young peopleQS125
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA779

Results per page

  1. 10
  2. 25
  3. 50
  4. All